Improving Clinical Outcomes in Peripheral Interventions with Boston Scientific

Part 1: Prof Stephen Black (Guys and St Thomas NHS Foundation Trust, UK) and Dr Stefano Barco (University Hospital Zurich, CH) share their extensive experiences in treating patients with ilio-femoral DVT, protocols and treatment pathways.

A number of live audience polls during the session revealed that the audience believed their practices would significantly grow with the majority treating patients with acute DVT but challenges to treat more patients relate hospital infrastructure, costs and seeing the patient early enough.

Key takeaways:

• Review of evidence favours patients with early thrombus removal and reduces severity of Post Thrombotic Syndrome (PTS)
• Pharmacomechanical Thrombectomy remains the gold standard. AngioJet with Powerpulse offers good efficacy and safety profile
• Patient selection is crucial
• Focus on the details, by incorporating contemporary practices its possible to achieve very low rates of PTS and low complication rates

Part 2: Prof Martin Andrassy (Fuerst-Stirum Hospital, DE) and Dr Gigorios Korosoglou (GRN Hospital Weinheim, DE) presenting their data about the use of Jetstream™ Atherectomy combined with Drug Coated Balloons, to treat femoropopliteal long complex lesions and femoropopliteal lesions with in-stent restenosis and occlusions.

Key take-aways:

• Using atherectomy improves lumen gain, decreases dissection, reduces bail-out stent rate and potentially optimizes drug delivery to the vessel wall
• Combining atherectomy and adjunctive therapy to treat long, complex, (non-) occlusive lesions is safe and effective
• Using atherectomy for in-stent restenosis and occlusions is safe and effective
• For in-stent restenosis the use of embolic protection is recommended